164 related articles for article (PubMed ID: 2541068)
1. The generation of hybridomas secreting human monoclonal antibodies reactive with type II collagen.
Posner MR; Barrach HJ; Elboim HS; Nivens K; Santos DJ; Chichester CO; Lally EV
Hybridoma; 1989 Apr; 8(2):187-97. PubMed ID: 2541068
[TBL] [Abstract][Full Text] [Related]
2. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies reactive with cell surface antigens on human leukemia cell lines: many antibodies are (auto)antibodies.
Posner MR; Elboim HS; Tumber MB; Cannon TJ
Hybridoma; 1990 Apr; 9(2):97-110. PubMed ID: 2161404
[TBL] [Abstract][Full Text] [Related]
4. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
[TBL] [Abstract][Full Text] [Related]
5. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
6. The production of human monoclonal autoantibodies from patients with rheumatoid arthritis by the EBV-hybridoma technique.
Haskard DO; Archer JR
J Immunol Methods; 1984 Nov; 74(2):361-7. PubMed ID: 6094669
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
8. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
9. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
[TBL] [Abstract][Full Text] [Related]
10. Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes.
Holmdahl R; Andersson M; Tarkowski A
Immunology; 1987 Jul; 61(3):369-74. PubMed ID: 2440798
[TBL] [Abstract][Full Text] [Related]
11. Generation of mouse-human hybridomas secreting human monoclonal antibodies to Japanese cedar pollen allergen Cry j1.
Naganawa Y; Shinmoto H; Shimmoto M
Hum Antibodies; 2005; 14(1-2):27-31. PubMed ID: 16424598
[TBL] [Abstract][Full Text] [Related]
12. An extreme strategy for the production of hybridoma.
Golestani R; Pourfathollah AA; Moazzeni SM
Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
[TBL] [Abstract][Full Text] [Related]
13. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
14. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
15. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
Tokunaga T; Chiba J; Ohnishi K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
[TBL] [Abstract][Full Text] [Related]
16. A human-mouse hybridoma which secretes monoclonal thyroglobulin autoantibody with properties similar to those of the donor patient's serum autoantibody.
Petersen VB; Fukuma N; McLachlan SM; Bradbury J; Beever K; Devey ME; Bleasdale-Barr KM; Phillips DI; Baylis P; Ryley H
Autoimmunity; 1989; 4(1-2):89-102. PubMed ID: 2562381
[TBL] [Abstract][Full Text] [Related]
17. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
18. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
19. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
20. A human anti-Jkb monoclonal antibody.
Lecointre-Coatmelec M; Bourel D; Ferrette J; Genetet B
Vox Sang; 1991; 61(4):255-7. PubMed ID: 1663674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
